Answers are grounded in this paper and cite their sources.
Equine sarcoidosis is a rare, complex disorder characterised by granulomatous inflammation of one or multiple organ systems. Depending on the location of granulomatous lesions in the body, equine sarcoidosis is further subdivided into a localised, partly generalised or generalised form. The clinical picture of this disease varies greatly. Affected horses most commonly present with exfoliative dermatitis with or without alopecia on single lower limbs, but other body parts can also be affected by the localised form. Lesions can stay confined to the skin in an otherwise healthy animal or affect other organ systems and cause severe systemic symptoms. Depending on the magnitude of affected organs, three forms of sarcoidosis are distinguished. The localised form is generally manageable, while the partly generalised and generalised form usually carry a poor prognosis. The causative agent of sarcoidosis has not yet been identified. Currently, an exaggerated immune response to one or multiple triggering agents seems to be the most likely explanation for the development of this disorder. The disease is diagnosed by the exclusion of differential diagnoses and evidence of granulomatous inflammation in histopathology. Treatment of sarcoidosis usually consists of systemic long-term treatment with immunosuppressive agents like corticosteroids or methotrexate. Maintenance therapy at lower doses is usually required to permanently stop disease progression.
No takes yet. Share an insight, caveat, or question.
Wimmer-Scherr et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: